{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:28:11Z","timestamp":1791325691107,"version":"4.3.1"},"reference-count":93,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1016\/j.vph.2005.03.004","type":"journal-article","created":{"date-parts":[[2005,6,14]],"date-time":"2005-06-14T11:25:50Z","timestamp":1118748350000},"page":"19-29","source":"Crossref","is-referenced-by-count":245,"title":["Vascular endothelin in hypertension"],"prefix":"10.1016","volume":"43","author":[{"given":"Ernesto L.","family":"Schiffrin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2005.03.004_bib1","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1161\/01.CIR.0000144462.08345.B9","article-title":"Endothelium-restricted overexpression of human endothelin-1 causes vascular remodelling and endothelial dysfunction","volume":"110","author":"Amiri","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2005.03.004_bib2","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1161\/01.CIR.103.2.319","article-title":"Myocardial fibrosis in DOCA-salt hypertensive rats: effect of endothelin ET(A) receptor antagonism","volume":"103","author":"Ammarguellat","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2005.03.004_bib3","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1161\/hy0202.103481","article-title":"Fibrosis, matrix metalloproteinases, and inflammation in the heart of DOCA-salt hypertensive rats: role of ET(A) receptors","volume":"39","author":"Ammarguellat","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.vph.2005.03.004_bib4","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/j.1476-5381.1996.tb15292.x","article-title":"Endothelin receptors in human coronary artery and aorta","volume":"117","author":"Bacon","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.vph.2005.03.004_bib5","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000077288","article-title":"Activation of resistance arteries with endothelin-1: from vasoconstriction to functional adaptation and remodeling","volume":"41","author":"Bakker","year":"2004","journal-title":"J. Vasc. Res."},{"key":"10.1016\/j.vph.2005.03.004_bib6","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1046\/j.1365-2362.2002.00974.x","article-title":"Endothelin ETA receptor-subtype specific antagonism does not mitigate the acute systemic or renal effects of exogenous angiotensin II in humans","volume":"32","author":"Bayerle-Eder","year":"2002","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.vph.2005.03.004_bib7","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1172\/JCI114477","article-title":"Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide","volume":"85","author":"Boulanger","year":"1990","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.vph.2005.03.004_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-201X.2004.01270.x","article-title":"Force-independent expression of c-fos mRNA by endothelin-1 in rat intact small mesenteric arteries","volume":"181","author":"Buus","year":"2004","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.vph.2005.03.004_bib9","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1161\/01.HYP.0000088363.65943.6C","article-title":"ETA receptor blockade decreases vascular superoxide generation in DOCA-salt hypertension","volume":"42","author":"Callera","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.vph.2005.03.004_bib10","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1161\/01.CIR.0000130590.24107.D3","article-title":"Ethnic differences in the vasoconstrictor activity of endogenous endothelin-1 in hypertensive patients","volume":"109","author":"Campia","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2005.03.004_bib11","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1161\/01.HYP.33.2.753","article-title":"Role of endothelin in the increased vascular tone of patients with essential hypertension","volume":"33","author":"Cardillo","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.vph.2005.03.004_bib12","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1161\/hc0402.102989","article-title":"Improved endothelium-dependent vasodilation after blockade of endothelin receptors in patients with essential hypertension","volume":"105","author":"Cardillo","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2005.03.004_bib13","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1097\/00005344-200000002-00012","article-title":"Endothelin and pulmonary hypertension","volume":"35","author":"Chen","year":"2000","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.vph.2005.03.004_bib14","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1242\/dev.125.5.813","article-title":"Cranial and cardiac neural crest defects in endothelin-A receptor-deficient mice","volume":"125","author":"Clouthier","year":"1998","journal-title":"Development"},{"key":"10.1016\/j.vph.2005.03.004_bib15","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1164\/ajrccm.165.3.2104059","article-title":"ET(A) and ET(B)-receptors modulate the proliferation of human pulmonary artery smooth muscle cells","volume":"165","author":"Davie","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.vph.2005.03.004_bib16","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1161\/01.HYP.35.1.287","article-title":"Endothelin-1 attenuates omega3 fatty acid-induced apoptosis by inhibition of caspase 3","volume":"35","author":"Diep","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.vph.2005.03.004_bib17","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1161\/01.HYP.0000037969.41360.CC","article-title":"PPAR\u03b1 activator effects on Ang II-induced vascular oxidative stress and inflammation","volume":"40","author":"Diep","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.vph.2005.03.004_bib18","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1161\/01.CIR.0000016049.86468.23","article-title":"Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats. Role of peroxisome proliferator-activated receptor-\u03b3","volume":"105","author":"Diep","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2005.03.004_bib19","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1139\/y03-032","article-title":"Synthesis and degradation of endothelin-1","volume":"81","author":"D'Orl\u00e9ans-Juste","year":"2003","journal-title":"Can. J. Physiol. Pharm."},{"key":"10.1016\/j.vph.2005.03.004_bib20","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0140-6736(01)06298-5","article-title":"Endothelin-receptor antagonists in pulmonary hypertension","volume":"358","author":"Dupuis","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.vph.2005.03.004_bib21","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1161\/01.HYP.28.4.652","article-title":"Racial differences in plasma endothelin-1 concentrations in individuals with essential hypertension","volume":"28","author":"Ergul","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.vph.2005.03.004_bib22","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00005344-199909000-00002","article-title":"Distribution of endothelin receptors in saphenous veins of African Americans: implications of racial differences","volume":"34","author":"Ergul","year":"1999","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.vph.2005.03.004_bib23","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1681\/ASN.V12122701","article-title":"Angiotensin II activates collagen type I gene in the renal cortex and aorta of transgenic mice through interaction with endothelin and TGF-beta","volume":"12","author":"Fakhouri","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.vph.2005.03.004_bib24","first-page":"254","article-title":"Epidermal growth factor receptor transactivation mediates the tonic and fibrogenic effects of endothelin in the aortic wall of transgenic mice","volume":"16","author":"Flamant","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.vph.2005.03.004_bib25","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/00004872-200404000-00016","article-title":"Genes encoding endothelin-converting enzyme-1 and endothelin-1 interact to influence blood pressure in women: the EVA study","volume":"22","author":"Funalot","year":"2004","journal-title":"J. Hypertens."},{"key":"10.1016\/j.vph.2005.03.004_bib26","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/hmg\/ddg040","article-title":"Differential binding of transcription factor E2F-2 to the endothelin-converting enzyme-1b promoter affects blood pressure regulation","volume":"12","author":"Funke-Kaiser","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.vph.2005.03.004_bib27","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1161\/01.CIR.0000118499.69469.51","article-title":"Endothelin-A receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure: a comparison of selective and combined endothelin receptor blockade","volume":"109","author":"Goddard","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2005.03.004_bib28","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1161\/01.ATV.0000023160.67766.F0","article-title":"Saphenous vein endothelin system expression and activity in African American patients","volume":"22","author":"Grubbs","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2005.03.004_bib29","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1172\/JCI117470","article-title":"Direct and sympathetically mediated venoconstriction in essential hypertension. Enhanced responses to endothelin-1","volume":"94","author":"Haynes","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.vph.2005.03.004_bib30","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/S0735-1097(02)01798-9","article-title":"Chronic endothelin receptor antagonism prevents coronary vasa vasorum neovascularization in experimental hypercholesterolemia","volume":"39","author":"Herrmann","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.vph.2005.03.004_bib31","doi-asserted-by":"crossref","first-page":"C550","DOI":"10.1152\/ajpcell.1985.248.5.C550","article-title":"Characterization of a coronary vasoconstrictor produced by cultured endothelial cells","volume":"248","author":"Hickey","year":"1985","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.vph.2005.03.004_bib32","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/00004872-200404000-00013","article-title":"Plasma endothelin-1 level is related to renal function and smoking status but not to blood pressure: an epidemiological study","volume":"22","author":"Hirai","year":"2004","journal-title":"J. Hypertens."},{"key":"10.1016\/j.vph.2005.03.004_bib33","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1161\/hc0402.102863","article-title":"Involvement of nuclear factor-kappaB and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy","volume":"105","author":"Hirotani","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2005.03.004_bib34","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cardiores.2003.10.019","article-title":"Angiotensin II induces endothelin-1 gene expression via extracellular signal-regulated kinase pathway in rat aortic smooth muscle cells","volume":"61","author":"Hong","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.vph.2005.03.004_bib35","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/0092-8674(94)90017-5","article-title":"Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice","volume":"79","author":"Hosoda","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.vph.2005.03.004_bib36","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMra040291","article-title":"Treatment of pulmonary arterial hypertension","volume":"351","author":"Humbert","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2005.03.004_bib37","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1161\/hq1001.097065","article-title":"Chronic blockade of endothelin receptors improves ischemia-induced angiogenesis in rat hindlimbs through activation of vascular endothelial growth factor-NO pathway","volume":"21","author":"Iglarz","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2005.03.004_bib38","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1161\/hy0202.103442","article-title":"Preproendothelin-1 gene polymorphism is related to a change in vascular reactivity in the human mammary artery in vitro","volume":"39","author":"Iglarz","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.vph.2005.03.004_bib39","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1161\/01.ATV.0000047447.67827.CD","article-title":"Effect of peroxisome proliferator-activated receptor-\u03b1 and -\u03b3 activators on vascular remodeling in endothelin-dependent hypertension","volume":"23","author":"Iglarz","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2005.03.004_bib40","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1161\/01.HYP.36.3.312","article-title":"Structure and mechanical properties of resistance arteries in hypertension: role of adhesion molecules and extracellular matrix determinants","volume":"36","author":"Intengan","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.vph.2005.03.004_bib41","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1006\/jmcc.2000.1178","article-title":"Oxidative stress increases synthesis of big endothelin-1 by activation of the endothelin-1 promoter","volume":"32","author":"Kahler","year":"2000","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.vph.2005.03.004_bib42","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00005344-200107000-00006","article-title":"Oxidative stress increases endothelin-1 synthesis in human coronary artery smooth muscle cells","volume":"38","author":"Kahler","year":"2001","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.vph.2005.03.004_bib43","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1023\/A:1015630513908","article-title":"Endothelin-1 as a target for therapeutic intervention in prostate cancer","volume":"20","author":"Kopetz","year":"2002","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.vph.2005.03.004_bib44","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/01.HYP.0000052542.68896.2B","article-title":"Myocardial ultrasonic backscatter in hypertension\u2014relation to aldosterone and endothelin","volume":"41","author":"Koz\u00e0kov\u00e0","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.vph.2005.03.004_bib45","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1056\/NEJM199803193381202","article-title":"The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension Investigators","volume":"338","author":"Krum","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2005.03.004_bib46","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/368703a0","article-title":"Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1","volume":"368","author":"Kurihara","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.vph.2005.03.004_bib47","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1161\/01.HYP.21.3.294","article-title":"Increased endothelin-1 content in blood vessels of deoxycorticosterone acetate-salt hypertensive but not in spontaneously hypertensive rats","volume":"21","author":"Larivi\u00e8re","year":"1993","journal-title":"Hypertension"},{"key":"10.1016\/j.vph.2005.03.004_bib48","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1161\/01.HYP.34.4.795","article-title":"Cardiac microvasculature in DOCA-salt hypertensive rats: effect of endothelin ET(A) receptor antagonism","volume":"34","author":"Larouche","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.vph.2005.03.004_bib49","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1161\/01.HYP.24.2.183","article-title":"Effect of a nonselective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate-salt hypertensive rats. Evidence for a role of endothelin in vascular hypertrophy","volume":"24","author":"Li","year":"1994","journal-title":"Hypertension"},{"key":"10.1016\/j.vph.2005.03.004_bib50","doi-asserted-by":"crossref","first-page":"H88","DOI":"10.1152\/ajpheart.1996.271.1.H88","article-title":"Effect of endothelin antagonism on blood pressure and vascular structure in renovascular hypertensive rats","volume":"40","author":"Li","year":"1996","journal-title":"Am. J. Physiol., Heart Circ. Physiol."},{"key":"10.1016\/j.vph.2005.03.004_bib51","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1161\/01.CIR.0000051459.74466.46","article-title":"Endothelin-1 increases vascular superoxide via endothelinA-NADPH oxidase pathway in low-renin hypertension","volume":"107","author":"Li","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2005.03.004_bib52","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0891-5849(01)00822-X","article-title":"Hydrogen peroxide regulation of bovine endothelin-converting enzyme-1","volume":"32","author":"Lopez-Ongil","year":"2002","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.vph.2005.03.004_bib53","doi-asserted-by":"crossref","first-page":"C389","DOI":"10.1152\/ajpcell.1992.263.2.C389","article-title":"Physiological fluid shear stress causes downregulation of endothelin-1 mRNA in bovine aortic endothelium","volume":"263","author":"Malek","year":"1992","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.vph.2005.03.004_bib54","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1023\/A:1015195803445","article-title":"Involvement of nuclear factor-kappaB in endothelin-A-receptor-induced proliferation and inhibition of apoptosis","volume":"21","author":"Mangelus","year":"2001","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.vph.2005.03.004_bib55","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1161\/01.HYP.32.1.89","article-title":"Stimulatory interaction between vascular endothelial growth factor and endothelin-1 on each gene expression","volume":"32","author":"Matsuura","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.vph.2005.03.004_bib56","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1161\/01.HYP.0000088361.26773.08","article-title":"Endothelin-A receptors mediate renal hemodynamic effects of exogenous angiotensin II in humans","volume":"42","author":"Montanari","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.vph.2005.03.004_bib57","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/0006-291X(92)91163-K","article-title":"Venous smooth muscle contains vasoconstrictor ETB-like receptors","volume":"184","author":"Moreland","year":"1992","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.vph.2005.03.004_bib58","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1161\/01.CIR.96.6.1976","article-title":"Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling","volume":"96","author":"Mulder","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2005.03.004_bib59","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1161\/01.HYP.36.2.282","article-title":"Effect of bosentan on NF-kappaB, inflammation, and tissue factor in angiotensin II-induced end-organ damage","volume":"36","author":"Muller","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.vph.2005.03.004_bib60","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/01.HYP.0000039748.88581.A0","article-title":"Endothelin-converting enzyme inhibition ameliorates angiotensin II-induced cardiac damage","volume":"40","author":"Muller","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.vph.2005.03.004_bib61","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1074\/jbc.M208949200","article-title":"Heterodimerization of endothelin-converting enzyme-1 isoforms regulates the subcellular distribution of this metalloprotease","volume":"278","author":"Muller","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.vph.2005.03.004_bib62","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0895-7061(02)02933-3","article-title":"Darusentan: an effective endothelin A receptor antagonist for treatment of hypertension","volume":"15","author":"Nakov","year":"2002","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.vph.2005.03.004_bib63","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1074\/jbc.272.3.1747","article-title":"Permissive role of nitric oxide in endothelin-induced migration of endothelial cells","volume":"272","author":"Noiri","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.vph.2005.03.004_bib64","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1161\/01.HYP.37.6.1444","article-title":"ET(A) receptor antagonist prevents blood pressure elevation and vascular remodeling in aldosterone-infused rats","volume":"37","author":"Park","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.vph.2005.03.004_bib65","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0895-7061(01)02291-9","article-title":"Cardiac and vascular fibrosis and hypertrophy in aldosterone-infused rats: role of endothelin-1","volume":"15","author":"Park","year":"2002","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.vph.2005.03.004_bib66","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0895-7061(01)02233-6","article-title":"Chronic treatment with a superoxide dismutase mimetic prevents vascular remodeling and progression of hypertension in salt-loaded stroke-prone spontaneously hypertensive rats","volume":"15","author":"Park","year":"2002","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.vph.2005.03.004_bib67","first-page":"F326","article-title":"Endothelin inhibits thick ascending limb chloride flux via ET(B) receptor-mediated NO release","volume":"279","author":"Plato","year":"2000","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.vph.2005.03.004_bib68","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1161\/01.HYP.0000078357.92682.EC","article-title":"Endothelin antagonism on aldosterone-induced oxidative stress and vascular remodeling","volume":"42","author":"Pu","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.vph.2005.03.004_bib69","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1161\/01.RES.0000014226.74709.90","article-title":"Leptin induces endothelin-1 in endothelial cells in vitro","volume":"90","author":"Quehenberger","year":"2002","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2005.03.004_bib70","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/01.HYP.30.1.29","article-title":"Role for endothelin-1 in angiotensin II-mediated hypertension","volume":"30","author":"Rajagopalan","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.vph.2005.03.004_bib71","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1161\/01.ATV.20.4.949","article-title":"Blockade of angiotensin II type 1 receptor and not of endothelin receptor prevents hypertension and cardiovascular disease in transgenic (mREN2)27 rats via adrenocortical steroid-independent mechanisms","volume":"20","author":"Rossi","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2005.03.004_bib72","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1097\/00004872-200312000-00028","article-title":"Renal damage is not improved by blockade of endothelin receptors in primary renin-dependent hypertension","volume":"21","author":"Rothermund","year":"2003","journal-title":"J. Hypertens."},{"key":"10.1016\/j.vph.2005.03.004_bib73","doi-asserted-by":"crossref","first-page":"S346","DOI":"10.1097\/00005344-199526003-00103","article-title":"Characterization of endothelin receptors in the human pulmonary vasculature using bosentan, SB209670, and 97\u2013139","volume":"26","author":"Russell","year":"1995","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.vph.2005.03.004_bib74","first-page":"R243","article-title":"Renal endothelin in chronic angiotensin II hypertension","volume":"283","author":"Sasser","year":"2002","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.vph.2005.03.004_bib75","first-page":"L668","article-title":"Effects of separate and combined ETA and ETB blockade on ET-1-induced constriction in perfused rat lungs","volume":"269","author":"Sato","year":"1995","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.vph.2005.03.004_bib76","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/01.HYP.25.6.1135","article-title":"Endothelin: potential role in hypertension and vascular hypertrophy","volume":"25","author":"Schiffrin","year":"1995","journal-title":"Hypertension"},{"issue":"Part 2","key":"10.1016\/j.vph.2005.03.004_bib77","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1161\/01.HYP.34.4.876","article-title":"Role of endothelin-1 in hypertension","volume":"34","author":"Schiffrin","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.vph.2005.03.004_bib78","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1097\/00004872-200312000-00010","article-title":"The angiotensin\u2013endothelin relationship: does it play a role in cardiovascular and renal pathophysiology? Editorial commentary","volume":"21","author":"Schiffrin","year":"2003","journal-title":"J. Hypertens."},{"key":"10.1016\/j.vph.2005.03.004_bib79","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00004872-199715010-00005","article-title":"Enhanced expression of endothelin-1 gene in resistance arteries in severe human essential hypertension","volume":"15","author":"Schiffrin","year":"1997","journal-title":"J. Hypertens."},{"key":"10.1016\/j.vph.2005.03.004_bib80","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1161\/01.HYP.0000084370.74777.B6","article-title":"Peroxisome proliferators-activated receptors: vascular and cardiac effects in hypertension","volume":"42","author":"Schiffrin","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.vph.2005.03.004_bib81","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1161\/01.HYP.30.5.1198","article-title":"Endothelin-1 as an autocrine\/paracrine apoptosis survival factor for endothelial cells","volume":"30","author":"Shichiri","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.vph.2005.03.004_bib82","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0735-1097(00)01123-2","article-title":"Redox regulation of MAPK pathways and cardiac hypertrophy in adult rat cardiac myocyte","volume":"37","author":"Tanaka","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.vph.2005.03.004_bib83","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1161\/01.HYP.33.5.1169","article-title":"The Lys198Asn polymorphism in the endothelin-1 gene is associated with blood pressure in overweight people","volume":"33","author":"Tiret","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.vph.2005.03.004_bib84","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1097\/00005344-200206000-00015","article-title":"Endothelin A receptor blockade decreases expression of growth factors and collagen and improves matrix metalloproteinase-2 activity in kidneys from stroke-prone spontaneously hypertensive rats","volume":"39","author":"Tostes","year":"2002","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.vph.2005.03.004_bib85","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/00004872-200406000-00015","article-title":"Angiotensin II and endothelin-1 regulate MAP kinases through different redox-dependent mechanisms in human vascular smooth muscle cells","volume":"22","author":"Touyz","year":"2004","journal-title":"J. Hypertens."},{"key":"10.1016\/j.vph.2005.03.004_bib86","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1046\/j.1432-1327.1999.00602.x","article-title":"A fourth isoform of endothelin-converting enzyme (ECE-1) is generated from an additional promoter molecular cloning and characterization","volume":"264","author":"Valdenaire","year":"1999","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.vph.2005.03.004_bib87","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1161\/01.CIR.97.8.752","article-title":"Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade","volume":"97","author":"Verhaar","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2005.03.004_bib88","doi-asserted-by":"crossref","first-page":"16066","DOI":"10.1016\/S0021-9258(18)41966-7","article-title":"Polar secretion of endothelin-1 by cultured endothelial cells","volume":"267","author":"Wagner","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.vph.2005.03.004_bib89","first-page":"L1058","article-title":"ET-1 stimulates pulmonary arterial smooth muscle cell proliferation via induction of reactive oxygen species","volume":"281","author":"Wedgwood","year":"2001","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.vph.2005.03.004_bib90","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1161\/01.RES.85.8.682","article-title":"Simulated ischemia in flow-adapted endothelial cells leads to generation of reactive oxygen species and cell signaling","volume":"85","author":"Wei","year":"1999","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2005.03.004_bib91","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/332411a0","article-title":"A novel potent vasoconstrictor peptide produced by vascular endothelial cells","volume":"332","author":"Yanagisawa","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.vph.2005.03.004_bib92","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1161\/01.CIR.82.1.188","article-title":"Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries. A new mechanism of vasospasm?","volume":"2","author":"Yang","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2005.03.004_bib93","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1097\/00005344-200112000-00006","article-title":"Endothelin-1 production is enhanced by rotenone, a mitochondrial complex I inhibitor, in cultured rat cardiomyocytes","volume":"38","author":"Yuhki","year":"2001","journal-title":"J. Cardiovasc. Pharmacol."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189105000960?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189105000960?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,11]],"date-time":"2021-07-11T21:04:15Z","timestamp":1626037455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189105000960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":93,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S1537189105000960"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2005.03.004","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}